VDR and chronic kidney disease: Depending on the stage, CKD can reduce not only renal 1α-hydroxylase and the amount of filtered 25(OH)D but also renal megalin content and the uptake of 25(OH)D by monocytes–macrophages, markedly impairing both endocrine and autocrine VDR activation (7, 8).